fluconazole has been researched along with Blindness in 7 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
Blindness: The inability to see or the loss or absence of perception of visual stimuli. This condition may be the result of EYE DISEASES; OPTIC NERVE DISEASES; OPTIC CHIASM diseases; or BRAIN DISEASES affecting the VISUAL PATHWAYS or OCCIPITAL LOBE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Candida albicans osteomyelitis is a rare disease that occurs in immunocompromised individuals, sometimes with a late diagnosis related to the mismatch between symptoms and candidemia." | 1.42 | Candida albicans osteomyelitis as a cause of chest pain and visual loss. ( Cortez, J; Magano, R; Ramos, E; Trindade, L, 2015) |
| "albicans endophthalmitis was diagnosed for 15 IVDAs." | 1.30 | Candida albicans endophthalmitis in brown heroin addicts: response to early vitrectomy preceded and followed by antifungal therapy. ( Bordón, J; de la Fuente, J; Fernández-Ulloa, J; Martínez-Vázquez, C; Ocampo, A; Rubianes, M; Sopeña, B, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Johnson, KL | 1 |
| James, MD | 1 |
| Carrera-Justiz, S | 1 |
| Magano, R | 1 |
| Cortez, J | 1 |
| Ramos, E | 1 |
| Trindade, L | 1 |
| Guevara-Campos, J | 1 |
| González-Guevara, L | 1 |
| Urbéz-Cano, J | 1 |
| Fermín, S | 1 |
| Morera, N | 1 |
| Juan-Sallés, C | 1 |
| Torres, JM | 1 |
| Andreu, M | 1 |
| Sánchez, M | 1 |
| Zamora, MÁ | 1 |
| Colom, MF | 1 |
| Machan, M | 1 |
| Kestenbaum, T | 1 |
| Fraga, GR | 1 |
| Gibold, X | 1 |
| Husson, A | 1 |
| Corbain, V | 1 |
| Vidal, M | 1 |
| Gourdon, F | 1 |
| Laurichesse, H | 1 |
| Beytout, J | 1 |
| Irthum, P | 1 |
| Ferrier, A | 1 |
| Lesens, O | 1 |
| Martínez-Vázquez, C | 1 |
| Fernández-Ulloa, J | 1 |
| Bordón, J | 1 |
| Sopeña, B | 1 |
| de la Fuente, J | 1 |
| Ocampo, A | 1 |
| Rubianes, M | 1 |
7 other studies available for fluconazole and Blindness
| Article | Year |
|---|---|
What Is Your Neurologic Diagnosis?
Topics: Amphotericin B; Animals; Anti-Inflammatory Agents; Antifungal Agents; Blindness; Cat Diseases; Cats; | 2017 |
Candida albicans osteomyelitis as a cause of chest pain and visual loss.
Topics: Adult; Amphotericin B; Antifungal Agents; Blindness; Candida albicans; Candidiasis; Chest Pain; Fluc | 2015 |
[Cryptococcus neoformans meningoencephalitis in immunocompetent schoolchildren].
Topics: Amphotericin B; Animals; Animals, Domestic; Antifungal Agents; Blindness; Cerebrospinal Fluid; Child | 2009 |
Cryptococcus gattii infection in a Spanish pet ferret (Mustela putorius furo) and asymptomatic carriage in ferrets and humans from its environment.
Topics: Amplified Fragment Length Polymorphism Analysis; Animals; Anti-Inflammatory Agents; Antifungal Agent | 2011 |
Diffuse hyperkeratosis in a deaf and blind 48-year-old woman--quiz case. Diagnosis: keratitis-ichthyosis-deafness (KID) syndrome with secondary dermatophytosis.
Topics: Antifungal Agents; Baths; Blindness; Deafness; Dermatologic Agents; Female; Fluconazole; Humans; Ich | 2012 |
[Cryptococcal meningitis disclosed by visual loss in HIV negative patient with ventriculo-atrial shunting].
Topics: Amphotericin B; Anti-Inflammatory Agents; Antifungal Agents; Blindness; Cerebrospinal Fluid Shunts; | 2006 |
Candida albicans endophthalmitis in brown heroin addicts: response to early vitrectomy preceded and followed by antifungal therapy.
Topics: Adult; Amphotericin B; Antifungal Agents; Blindness; Candidiasis; Combined Modality Therapy; Endopht | 1998 |